Psychiatric disorders in patients with immune-mediated inflammatory diseases: Prevalence, association with disease activity, and overall patient well-being

Journal of Rheumatology

Volumn 38, Issue SUPPL. 88, 2011, Pages 31-35

  Walker, John R ^a   Graff, Lesley A ^a   Dutz, Jan P ^b   Bernstein, Charles N ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Section of Gastroenterology   (Canada)

Author keywords

Anxiety; Depression; Immune mediated inflammatory diseases; Inflammation

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

ANXIETY DISORDER; COMORBIDITY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISTRESS SYNDROME; DRUG RESPONSE; ENTERITIS; HUMAN; IMMUNE MEDIATED INFLAMMATORY DISEASE; IMMUNOPATHOLOGY; PATIENT CARE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; HOSPITALIZATION; PATHOPHYSIOLOGY; PREVALENCE;

ANXIETY DISORDERS; ARTHRITIS, RHEUMATOID; DEPRESSIVE DISORDER; HUMANS; INFLAMMATORY BOWEL DISEASES; PREVALENCE; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84863393129     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110900     Document Type: Review

References (43)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27. (Pubitemid 40973437)
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602. (Pubitemid 40973434)
3. Kendler KS, Prescott CA, editors. Genes, environment, and psychopathology: understanding the causes of psychiatric and substance use disorders. New York: Guilford Press; 2007.
4. Patten SB, Beck CA, Kassam A, Williams JV, Barbui C, Metz LM. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry 2005;50:195-202. (Pubitemid 41583256)
5. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002;53:859-63. (Pubitemid 35282614)
6. Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health surveys. J Affect Disord 2007;103:113-20. (Pubitemid 47454644)
7. Kessler RC, Ormel J, Demler O, Stang PE. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: Results from the National Comorbidity Survey. J Occup Environ Med 2003;45:1257-66. (Pubitemid 37541939)
8. Buist-Bouwman MA, de Graaf R, Vollebergh WA, Ormel J. Comorbidity of physical and mental disorders and the effect on work-loss days. Acta Psychiatr Scand 2005;111:436-43. (Pubitemid 40776288)
9. Rabin BS, Cohen S, Ganguli R, Lysle DT, Cunnick JE. Bidirectional interaction between the central nervous system and the immune system. Crit Rev Immunol 1989;9:279-312. (Pubitemid 19274410)
10. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights in pathogenic and therapeutic implications. Gut 2005;54:1481-91. (Pubitemid 41375207)
11. Leue C, van Os J, Neeleman J, de Graaf R, Vollebergh W, Stockbrügger RW. Bidirectional associations between depression/anxiety and bowel disease in a population based cohort. J Epidemiol Community Health 2005;59:434.
12. Rosenkranz MA. Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychol Bull 2007;133:1007-37.
13. Rook GAW, Lowry CA. The hygiene hypothesis and psychiatric disorders. Trends Immunol 2008;29:150-8.
14. Ghia J, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 2008;118:2209-18. (Pubitemid 351872339)
15. North CS, Clouse RE, Spitznagel EL, Alpers DH. The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am J Psychiatry 1990;147:974-81. (Pubitemid 20257504)
16. North CS, Alpers DH. A review of studies of psychiatric factors in Crohn's disease: Etiologic implications. Ann Clin Psychiatry 1994;6:117-24. (Pubitemid 24312175)
17. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007;13:225-34. (Pubitemid 46806232)
18. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995;25:1259-67.
19. Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study. Am J Gastroenterol 2007;102:122-31. (Pubitemid 46072052)
20. Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001;55:716-20. (Pubitemid 32881818)
21. Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008;103:1989-97.
22. Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 2004;49:492-7. (Pubitemid 38455480)
23. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79-84. (Pubitemid 38146536)
24. Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52-60. (Pubitemid 34137399)
25. Frank RG, Beck NC, Parker JC, Kashani JH, Elliott TR, Haut AE, et al. Depression in rheumatoid arthritis. J Rheumatol 1988;15:920-5.
26. Peck JR, Smith TW, Ward JR, Milano R. Disability and depression in rheumatoid arthritis: a multi-trait, multi-method investigation. Arthritis Rheum 1989;32:1100-6. (Pubitemid 19237864)
27. Wolfe F, Hawley DJ. The relationship between clinical activity and depression in rheumatoid arthritis. J Rheumatol 1993;20:2032-7. (Pubitemid 24043125)
28. Covic T, Tyson G, Spencer D, Howe G. Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors. J Psychosom Res 2006;60:469-76.
29. Godha D, Shi L, Mavronicolas H. Association between tendency towards depression and severity of rheumatoid arthritis from a national representative sample: the Medical Expenditure Panel Survey. Curr Med Res Opin 2010;26:1685-90.
30. Odegard S, Finset A, Mowinckel P, Kvien TK, Uhlig T. Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2007;66:1195-201. (Pubitemid 47309737)
31. Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000;43:2751-61. (Pubitemid 32001741)
32. Löwe B, Willand L, Eich W, Zipfel S, Ho AD, Herzog W, et al. Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseases. Psychosom Med 2004;66:395-402. (Pubitemid 38668412)
33. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32:1013-9. (Pubitemid 40828071)
34. Packham JC, Dawes PT, Hassell AB, Mattey DL. Does depression in rheumatoid arthritis affect the efficacy or side effect profile of anti-TNF therapy? Rheumatology 2007;46 Suppl 1:i46.
35. Hider SL, Tanveer W, Brownfield A, Mattey DL, Packham JC. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology 2009;48:1152-4.
36. Mattey DL, Dawes PT, Hassell AB, Brownfield A, Packham JC. Effect of psychological distress on continuation of anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. J Rheumatol 2010;37:2021-4.
37. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005;6:383-92. (Pubitemid 43128290)
38. Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med 2009;121:154-61.
39. Kirby B, Richards HL, Mason DL, Fortune DG, Main CJ, Griffiths CE. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008;158:138-40. (Pubitemid 350221922)
40. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010;146:891-5.
41. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009;15:1105-18.
42. Kulkarni AS, Balkrishnan R, Camacho FT, Anderson RT, Feldman SR. Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol 2004;3:661-6.
43. Rabin BS, Cohen S, Ganguli R, Lysle DT, Cunnick JE. Bidirectional interaction between the central nervous system and the immune system. Crit Rev Immunol 1989;9:279-312. (Pubitemid 19274410)